Literature DB >> 17156870

The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction.

A Dirkali, Tj van der Ploeg, M Nangrahary, J H Cornel, V A W M Umans.   

Abstract

UNLABELLED: Diabetes mellitus is a widely recognized risk factor for cardiovascular disease. Type 2 diabetics have a 3-fold increased risk of CAD; prediabetics, without chronic hyperglycemia, have a 2-fold increased risk compared with normal subjects. We determined in 615 consecutive acute infarction patients whether the admission plasma glucose level remains associated with major adverse cardiovascular events (MACE) in an unselected patient population with myocardial infarction. Of these, the mean age of 66+/-12 years (range 36-90) and 69% were men and mean APG and HbA1c level were 8.2+/-4.0 mmol/l and 6.1+/-1.1% respectively. 13.2% of total study population was already known with diabetes. We recorded 132 deaths (21.5%), of whom 23.6% were known diabetic patients during 2.5 years of follow-up Multivariate statistical analysis identified APG, older age and previous MI as independent mortality predictors.
CONCLUSION: Increased APG levels are significantly and independently correlated with poor prognosis after myocardial infarction, and this underlines the need for better medical treatment of hyperglycemic state and aggressive screening for early detection of diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17156870     DOI: 10.1016/j.ijcard.2006.08.107

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005-2007.

Authors:  Jakob Dörler; Hannes Franz Alber; Johann Altenberger; Gerhard Bonner; Werner Benzer; Georg Grimm; Kurt Huber; Lalit Kaltenbach; Karl-Peter Pfeiffer; Herwig Schuchlenz; Peter Siostrzonek; Gerald Zenker; Otmar Pachinger; Franz Weidinger
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

Review 2.  Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.

Authors:  Abdullah Kaplan; Emna Abidi; Ahmed El-Yazbi; Ali Eid; George W Booz; Fouad A Zouein
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

3.  Association of stress hyperglycemia and atrial fibrillation in myocardial infarction.

Authors:  Goran P Koracevic; Sladjana Petrovic; Miodrag Damjanovic; Teodora Stanojlovic
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  BNP and admission glucose as in-hospital mortality predictors in non-ST elevation myocardial infarction.

Authors:  Julio Yoshio Takada; Rogério Bicudo Ramos; Solange Desiree Avakian; Soane Mota dos Santos; José Antonio Franchini Ramires; Antonio de Pádua Mansur
Journal:  ScientificWorldJournal       Date:  2012-02-01

5.  Impact of admission blood glucose levels on prognosis of elderly patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention.

Authors:  Ahmet Ekmekci; Mahmut Uluganyan; Fatif Tufan; Huseyin Uyarel; Gurkan Karaca; Seref Kul; Barış Gungor; Gokhan Ertas; Betul Erer; Nurten Sayar; Mehmet Gul; Mehmet Eren
Journal:  J Geriatr Cardiol       Date:  2013-12       Impact factor: 3.327

6.  Diabetes mellitus and glucose as predictors of mortality in primary coronary percutaneous intervention.

Authors:  Renato Budzyn David; Eduardo Dytz Almeida; Larissa Vargas Cruz; Juliana Cañedo Sebben; Ivan Petry Feijó; Karine Elisa Schwarzer Schmidt; Luísa Martins Avena; Carlos Antonio Mascia Gottschall; Alexandre Schaan de Quadros
Journal:  Arq Bras Cardiol       Date:  2014-09-12       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.